Abstract
Severe combined immunodeficiency (SCID) is a potentially fatal disorder characterized by defective T- and B-lymphocyte function. We describe a 34-week female twin who had developed feeding intolerance, perioral cyanosis, abdominal distension and neutropenia at 1 month of age. Despite several evaluations including an ‘inconclusive’ newborn screening result for SCID, the presence of profound lymphopenia was unappreciated. Eventually a diagnosis of SCID in association with adenosine deaminase deficiency was made. This case serves to emphasize the importance of newborn screening for SCID in the context of careful evaluation of clinical and laboratory findings that may be overlooked and result in a delay in the diagnosis of a potentially life-threatening condition.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 2007; 120: 776–794.
Slatter MA, Gennery AR . Clinical immunology review series: an approach to the patient with recurrent infections in childhood. Clin Exp Immunol 2008; 152: 389–396.
Buckley RH . Primary immunodeficiency or not? Making the correct diagnosis. J Allergy Clin Immunol 2006; 117: 756–758.
Adeli MM, Buckley RH . Why newborn screening for severe combined immunodeficiency is essential: a case report. Pediatrics 2010; 126: e456–e461.
Brown L, Xu-Bayford J, Allwood Z, Slatter M, Cant A, Davies EG et al. Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screening. Blood 2011; 117: 3243–3246.
Buckley RH . The multiple causes of human SCID. J Clin Invest 2004; 114: 1409–1411.
Gaspar HB, Aiuti A, Porta F, Candotti F, Hershfield MS, Notarangelo LD et al. How I treat ADA deficiency. Blood 2009; 114: 3524–3532.
Booth C, Hershfield M, Notarangelo L, Buckley R, Hoenig M, Mahlaoui N et al. Management options for adenosine deaminase deficiency; proceedings of the EBMT satellite workshop (Hamburg, March 2006). Clin Immunol 2007; 123: 139–147.
Skolic R, Maric I, Kesserwan C, Garabedian E, Hanson IC, Dodds M et al. Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency. Blood 2011; 118: 2688–2694.
Christensen RD, Baer VL, Gordon PV, Henry E, Whitaker C, Andres RL et al. Reference ranges for lymphocyte counts of neonates: association between abnormal counts and outcomes. Pediatrics 2012; 129: e1165–e1172.
Puck JM . The case for newborn screening for severe combined immunodeficiency and related disorders. Ann NY Acad Sci 2011; 1246: 108–117.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Buchbinder, D., Puthenveetil, G., Soni, A. et al. Newborn screening for severe combined immunodeficiency: an opportunity for intervention. J Perinatol 33, 657–658 (2013). https://doi.org/10.1038/jp.2013.30
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2013.30